Apollon Financial’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88M Sell
37,974
-5,951
-14% -$302K 0.22% 96
2026
Q1
$2.34M Sell
43,925
-5,436
-11% -$319K 0.32% 75
2025
Q4
$3.07M Sell
49,361
-1,297
-3% -$80.1K 0.45% 60
2025
Q3
$3.04M Sell
50,658
-2,278
-4% -$139K 0.51% 51
2025
Q2
$3.32M Sell
52,936
-582
-1% -$35K 0.69% 40
2025
Q1
$3.22M Sell
53,518
-5,908
-10% -$367K 0.76% 34
2024
Q4
$3.47M Sell
59,426
-305
-0.5% -$18.1K 0.86% 26
2024
Q3
$3.54M Sell
59,731
-4,595
-7% -$262K 1.04% 24
2024
Q2
$3.6M Sell
64,326
-6,859
-10% -$384K 1.17% 21
2024
Q1
$4.17M Sell
71,185
-2,431
-3% -$137K 1.44% 20
2023
Q4
$3.97M Buy
+73,616
New +$3.6M 1.57% 20

Other funds holding IHI

Apollon Financial's IHI Position: Q2 2026 in Review

Apollon Financial reduced its iShares US Medical Devices ETF (IHI) stake by 14% in Q2 2026, selling an estimated $302K and leaving 37,974 shares worth $1.88M. The position accounts for 0.22% of the portfolio, ranked #96.

Apollon Financial first reported a position in IHI in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.17M in Q1 2024. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Apollon Financial held 37,974 shares of iShares US Medical Devices ETF worth $1.88M as of Q2 2026.
  • Apollon Financial sold 5,951 iShares US Medical Devices ETF shares in Q2 2026, an estimated $302K.
  • iShares US Medical Devices ETF made up 0.22% of Apollon Financial's portfolio in Q2 2026, its #96 holding.
  • Apollon Financial first reported a position in iShares US Medical Devices ETF in Q4 2023 and has held it in 11 quarters since.
  • Apollon Financial's iShares US Medical Devices ETF position peaked at $4.17M in Q1 2024.
  • 502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Apollon Financial's 13F filing for Q2 2026, filed 23 Jul 2026.